Calyxo is a medical device developer dedicated to improving the care of kidney stone patients by providing next-generation treatment solutions that enable urologists to safely, effectively and efficiently achieve unparalleled clinical outcomes. The company has developed a kidney stone retrieval device for the removal of kidney stone fragments, which allows multiple stone fragments to be extracted in a single insertion in seconds and provides unparalleled stone-free results, allowing physicians to use simple, intuitive The procedure completes the stone removal. Recently, Calyxo announced the completion of $32.7 million in Series C financing, led by Questa Capital and CRG.
This article is reproduced from: https://www.itjuzi.com/investevent/13329085
This site is for inclusion only, and the copyright belongs to the original author.